How DCTs Differ Across The Clinical Trial Landscape

The message was clear from industry leaders last year – today’s clinical trials need decentralized solutions. More complexity means intensive data capture and continuous flows are essential, and vital strategic decisions rely on real-time data analysis and intelligence. 

Existing point and unified solutions cannot fully meet the challenges and adapt to this dynamic world of decentralized trials, digital transformation, and data science.

Whether virtually or in-person, leaders emphasized that a holistic clinical technology platform is essential to enable decentralized clinical trials (DCT) today. Based upon the organization, clinical portfolio, and outsourcing model, DCT will look like many different things across the clinical trials landscape.